Market Overview - A-shares experienced mixed performance on July 29, with the Shanghai Composite Index showing slight fluctuations while the ChiNext Index rose over 1% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.13 trillion yuan, an increase of 67.3 billion yuan compared to the previous trading day [1] - Notable sectors included innovative drug stocks, which saw significant gains, while pesticide stocks faced collective adjustments [1] Sector Performance - Key sectors with notable gains included medical services, semiconductors, energy metals, CRO, CPO, and companies related to the China Shipbuilding Industry [2] - Conversely, sectors such as insurance, precious metals, chemical raw materials, pork, glyphosate, and prepared dishes experienced declines [2] Institutional Insights - Huatai Securities highlighted the acceleration of national fertility stimulus policies, which are expected to boost consumer confidence and improve demand for infant formula [3] - China International Capital Corporation (CICC) projected a rational release of coal supply in the second half of the year, potentially leading to a rebound in coal prices and industry profitability [3] - CITIC Securities noted that Hong Kong medical device companies are entering a phase of profitability, with several firms expected to see rapid performance releases [3] Logistics Industry Data - The total social logistics volume in China exceeded 171 trillion yuan in the first half of the year, reflecting a year-on-year growth of 5.6% [4] - The growth rate of social logistics outpaced GDP growth by 0.3 percentage points, indicating strong support from logistics demand for economic development [4] Regional Initiatives - Zhejiang Province plans to enhance cooperation with major stock exchanges to establish a "Technology Enterprise Cultivation Board" aimed at supporting high-quality development of specialized and innovative enterprises [5] - The initiative includes promoting regional equity market improvements and facilitating the listing of technology-oriented SMEs [5] Company Developments - China Chang'an Automobile Group Co., Ltd. was officially established in Chongqing, focusing on smart vehicles, flying cars, and other innovative production capabilities [6][7] - The new state-owned enterprise aims to accelerate globalization and expand into five major regional markets, including Southeast Asia and Europe [7]

Group 1 - The electric equipment industry is benefiting from the commencement of the Yarlung Tsangpo River downstream hydropower project, with a total investment of approximately 1.2 trillion yuan, expected to drive investments of 150 billion yuan in UHV and 30 billion yuan in GIL, leading to significant profit elasticity for related companies [1] - In June, the export value of electric equipment reached 6.76 billion USD, a year-on-year increase of 21%, with transformer and high-voltage switch exports growing by 46% and 29% respectively, indicating sustained high demand in overseas markets [1] - In the battery sector, the commercialization of semi-solid and all-solid-state batteries based on oxide polymer routes is anticipated to lead the market, offering better safety than liquid batteries while improving energy density and cycle life with limited cost increases [1] Group 2 - The active bidding for electrolyzers saw a significant increase in June, with an addition of 568 MW, accelerating green hydrogen projects, and the application of methanol fuel in shipping is promoting the consumption of green hydrogen, highlighting opportunities for hydrogen production equipment and green alcohol operators [1] - The ChiNext New Energy ETF (159387) tracks the Innovation Energy Index (399266), which can experience daily fluctuations of up to 20%, focusing on companies in the renewable energy and related technology sectors, including solar, wind, energy storage, and electric vehicles, reflecting the performance of companies with technological innovation capabilities and growth potential [1]

重点聊聊领涨板块，医药这厢全线走强，特别是CRO概念那帮哥们，奥翔药业和九洲药业直接涨停封板，药石科技更疯涨超17%，这热度，像夏天里的热炒 小龙虾，香得不行！背后啥逻辑？中长线角度看，这可能是机构在提前布局医药创新大趋势，毕竟政策风向和政策利好一直在撑腰，咱们盯稳点，别让机会 溜了。再看PET铜箔和半导体，方邦股份20厘米涨停、沃格光电也冲板、东芯股份20厘米封顶，半导体走高就像闷声发大财的代表，铜箔技术革新带动的行 情，长远看是AI和新能源赛道的延伸，中长线投资可别轻忽了这些小风口。 不过，也有翻车的。草甘膦板块全线下滑，连个红盘都没影儿，这调整力度挺大。保险板块也软了，新华保险和中国人保都跌超1%，说白点就是资金在轮 动换防，短炒行为居多。帮主我干了20年记者，明白一点：中长线玩的是耐心，别看调整个别板块就慌，盘面放量说明资金正在洗牌，找准结构性机会更重 要。这中午创业板领涨、医药扛大旗，虽个股普跌，但亮点是主流板块坚挺，资金可能正往硬核赛道靠拢。 收盘声里，午后咋样不敢瞎猜，但帮主我作为老股民建议：中长线就盯牢医药创新和半导体这些硬科技，别被短震吓跑。好了，盘面先聊到这儿，咱们下回 见，记得投资如马拉 ...

Group 1 - The core viewpoint is that the Science and Technology Innovation Board (STAR Market) has become a hub for "hard technology" companies in China, with total R&D investment expected to reach 168 billion yuan in 2024, a year-on-year increase of 6.4%, and a median revenue ratio of 12.67% [1] - The STAR Market is facilitating the financing of unprofitable companies through tiered management and professional institutional participation, directing funds towards hard technology sectors such as biomedicine, new energy, and semiconductors [1] - M&A activity has been robust since the beginning of 2025, with 73 new disclosed transactions completed, and 13 major transactions, nearing the total number of transactions from 2019 to 2023 [1] Group 2 - The Science and Technology Innovation and Entrepreneurship ETF (588360) tracks the Science and Technology Innovation 50 Index (931643), which selects high-growth and innovative companies from the STAR Market and the ChiNext board, covering high-tech fields like new generation information technology and biomedicine [2] - Investors without stock accounts can consider the Guotai CSI Science and Technology Innovation 50 ETF Initiated Link C (013307) and Link A (013306) [2]

注：如提及个股仅供参考，不代表投资建议。指数/基金短期涨跌幅及历史表现仅供分析参考，不预示 未来表现。市场观点随市场环境变化而变动，不构成任何投资建议或承诺。文中提及指数仅供参考，不 构成任何投资建议，也不构成对基金业绩的预测和保证。如需购买相关基金产品，请选择与风险等级相 匹配的产品。基金有风险，投资需谨慎。 每日经济新闻 国元证券指出，医保局系列座谈会明确了支持企业"反内卷"、开放出海、差异化创新等原则，利好医疗 器械行业高质量发展。集采价格有望进一步温和，促进企业盈利企稳提升；政策激发创新研发积极性， 新产品推动国产替代并打开成长空间；随着研发能力增强，政策助力中国创新药械全球化将为企业开拓 国际市场。医药生物行业方面，创新药进入成果兑现阶段，研发催化较多且不受贸易战影响，成为2025 年投资主线；出海领域在新兴市场布局的企业潜力大，集采出清后的细分赛道如胰岛素、骨科等有望迎 来新成长。行业集中度提升加速，并购重组或进一步活跃。 创业板医药ETF国泰（159377）跟踪的是创医药指数（399275），单日涨跌幅可达20%。该指数从创业 板市场中筛选专注于创新药物研发、生产及相关服务的上市公司证券作为指数 ...

金十数据7月29日讯，A股三大股指早盘接近平开后一度走低，随后创业板指持续走强午前涨超1%，沪 指、深证成指于平盘附近震荡。截至中午收盘，沪指跌0.08%，深证成指跌0.04%，创业板指涨0.92%； 沪深两市半日成交额超1.1万亿，超3600只个股下挫。盘面上，医药板块集体大涨，CRO、创新药等多 个细分领域表现强势，半导体板块涨幅居前，三胎概念冲高回落，保险、猪肉等板块跌幅居前。 A股午评：创业板指表现强势涨近1% 创新药板块集体大涨 ...

智通财经7月29日电，市场早盘震荡分化，三大指数涨跌不一，大小指数走势分化，中小盘股普跌。沪深两市半日成交额1.13万亿，较上个交易日放量67.3 亿。盘面上热点较为杂乱，个股跌多涨少，全市场超3800只个股下跌。从板块来看，医药股集体大涨，CRO、创新药方向领涨，辰欣药业等多股涨停。CPO 等算力硬件股震荡走强，中际旭创等多股再创历史新高。芯片股表现活跃，东芯股份20CM涨停。下跌方面，农药股展开调整，海利尔跌超5%。板块方面， CRO、创新药、半导体、CPO等板块涨幅居前，农药、农业、保险、猪肉等板块跌幅居前。截至收盘，沪指跌0.08%，深成指跌0.04%，创业板指涨0.92%。 | 上证指数 | | 深证成指 | 创业板指 | | --- | --- | --- | --- | | ·3595.19 | | ·11212.88 | -2384.23 | | -2.75 | -0.08% | -4.7 -0.04% | +21.63 +0.92% | | 700 | | 100 | 710 | 午评：创业板指半日涨0.92% 医药股持续爆发 洲宁衣现 封板率 63.00% 封板 31 触及 18 昨涨停今 ...

A股三大指数窄幅震荡，截至午间收盘，沪指跌0.08%，深成指跌0.04%，创业板指涨0.92%，北证50指 数跌0.04%，沪深京三市成交额11459亿元，较上日放量71亿元。两市超3800只个股下跌。 板块题材上，CRO、 PET铜箔、半导体板块走高，草甘膦、保险板块调整。 盘面上，CRO板块全线走高，奥翔药业（603229）、九洲药业（603456）涨停，药石科技（300725） 涨超17%。 PET铜箔早盘走强，方邦股份20CM涨停，沃格光电（603773）涨停、半导体板块走高，东 芯股份20CM涨停。草甘膦板块全线走低，板块全线飘绿无一上涨。保险板块调整，新华保险 （601336）、中国人保（601319）等跌超1%。 ...

Core Insights - The ChiNext ETF Ping An (159964) has shown a significant increase in value, with a recent rise of 0.72% and a weekly increase of 3.16% as of July 28, 2025 [1] - The ETF has achieved a net value increase of 15.66% over the past six months, with a maximum monthly return of 37.37% since its inception [2] - The ETF's management fee is 0.15%, and its tracking error over the past two months is 0.016%, indicating strong performance in tracking the ChiNext Index [4][5] Performance Metrics - As of July 28, 2025, the ChiNext ETF Ping An has a year-to-date relative drawdown of 0.13%, with a recovery period of 101 days, which is relatively quick compared to similar funds [3] - The ETF's average monthly return is 6.56%, with an annualized profit percentage of 60.00% [2] - The Sharpe ratio for the past month is 1.96, placing it in the top 3 out of 16 comparable funds, indicating higher returns for the same level of risk [2] Fund Composition - The ChiNext Index, which the ETF closely tracks, consists of 100 stocks with high market capitalization and liquidity, reflecting the performance of the ChiNext market [6] - As of June 30, 2025, the top ten weighted stocks in the ChiNext Index account for 51.16% of the index, with Ningde Times (300750) holding the highest weight at 18.77% [6][8]

创业板指涨超1%，沪指跌0.05%，深成指跌0.01%，创新药、算力硬件、半导体、乳业等方向领涨，沪 深京三市上涨个股近1400只。 ...